Mesyl phosphoramidate oligonucleotides as potential splice-switching agents: impact of backbone structure on activity and intracellular localization
A series of 2′-deoxy and novel 2′-O-methyl and 2′-O-(2-methoxyethyl) (2′-MOE) oligonucleotides with internucleotide methanesulfonyl (mesyl, μ) or 1-butanesulfonyl (busyl, β) phosphoramidate groups has been synthesized for evaluation as potential splice-switching oligonucleotides. Evaluation of their...
Main Authors: | Hammond, SM, Sergeeva, OV, Melnikov, PA, Goli, L, Stoodley, J, Zatsepin, TS, Stetsenko, DA, Wood, MJA |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Mary Ann Liebert
2021
|
Similar Items
-
Mesyl phosphoramidate backbone modified antisense oligonucleotides targeting miR-21 with enhanced in vivo therapeutic potency
by: Patutina, OA, et al.
Published: (2020) -
Use of cell-penetrating-peptides in oligonucleotide splice switching therapy.
by: El Andaloussi, SA, et al.
Published: (2012) -
Design and application of bispecific splice-switching oligonucleotides.
by: Bestas, B, et al.
Published: (2014) -
Backbone-modified oligonucleotides for biology and medicine
by: Epple, S
Published: (2021) -
Rational Design of Chimeric Antisense Oligonucleotides on a Mixed PO–PS Backbone for Splice-Switching Applications
by: Bao T. Le, et al.
Published: (2024-07-01)